Early access
Sign in
Taking people in SpainPhase 1

Testing iadademstat as a possible treatment for sickle cell disease

Tests iadademstat in adults with sickle cell disease.

Key facts

Who runs it
Oryzon Genomics S.A.
Where
Badalona, Barcelona, Madrid, and Sevilla, SpainSee the 7 sites
Registry title
Study of IADADEMSTAT for the Treatment of Sickle Cell Disease.
Status
Recruiting
Phase
Phase 1
People taking part
39 people, planned
Started
16 Oct 2025
Expected to end
1 Jan 2100
Type of study
Interventional
Record updated
17 July 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with sickle cell disease. It studies the medicine IADADEMSTAT.

Age
18 years or older
Sex
Men and women can join

Main reasons for not taking part

  • Healthy volunteers cannot join

Where in Spain

  • Institut Catala d'OncologiaBadalona, SpainTaking people
  • Hospital Clinic BarcelonaBarcelona, SpainTaking people
  • Hospital de la Santa Creu i Sant PauBarcelona, SpainTaking people
  • Hospital Universitari Vall d'HebronBarcelona, SpainTaking people
  • Hospital General Universitario Gregorio MarañónMadrid, SpainTaking people
  • Hospital Universitario La PazMadrid, SpainTaking people
  • University Hospital Virgen Del Rocio S.L.Sevilla, SpainTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record

Print a page for my doctor

Data and sources

Registry record
Listed on the EU's official list of trials (CTIS).
Plain-language title
Testing iadademstat as a possible treatment for sickle cell diseaseGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 9 November 2026.
Record updated
17 July 2026